INSIDEOUTBIO IMAGE: IMMUNE CELLS NEED TO BE CLOSE ENOUGH TO A TUMOR (WITHIN 150 Å) FOR A SYNAPSE TO FORM AND FOR THEM TO UNDERGO ACTIVATION. TUMORS USE THE EXTENDED FORM OF COMPLEMENT RECEPTOR 3 (CR 3) AND THE “I BELONG” TAB IC3B TO KEEP IMMUNE CELLS AT A DISTANCE. CREDIT: ALAN HERBERT In a...
Interview conducted by Emily Henderson, B.Sc. Professor Pockley among other researchers from the John van Geest Cancer Research Centre have recently developed a blood test for the detection of prostate cancer. News-Medical spoke to Professor Pockley to find out more! What provoked your research into the detection of prostate cancer? Why is there an urgent...
TRINITY COLLEGE DUBLIN When drugs to kill microbes are ineffective, host-directed therapy uses the body’s own immune system to deal with the infection. This approach is being tested in patients with COVID-19, and now a team of researchers at Trinity College Dublin has published a study showing how it might also work in the fight...
By RYAN MORRISON FOR MAILONLINE Researchers take a biopsy of a cancerous tumour to look for certain proteins Each patient has a ‘different cancer’ and the treatment is specifically targeted It is given alongside chemotherapy drugs to boost the body’s immune response So far only eight per cent of patients saw their tumour reduce but...
HOUSTON-(Oct. 23, 2018) – Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this nanofluidic seed makes it possible to deliver a one-time, sustained-release dose that would eliminate the need for patients to undergo several IV treatments over time. IMAGE: SMALLER THAN...
